# Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease

> **NCT01526850** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Graft Versus Host Disease

## Interventions

- **BIOLOGICAL:** Biological: mesenchymal stem cell
- **DRUG:** Cyclosporine and Glucocorticoid

## Key facts

- **NCT ID:** NCT01526850
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01526850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01526850, "Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01526850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*